Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HydroSanta Vaginalgel is a hormone-free medical device developed by Gynial GmbH for the relief and prevention of symptoms associated with vaginal dryness, such as itching, burning, and pain during intercourse (dyspareunia). The formulation contains 0.3% sodium hyaluronate, which acts as a humectant by binding water and forming a protective moisturizing film over the vaginal tissue. It also contains lactic acid to maintain the natural acidic pH of the vagina (3.8–4.5), thereby supporting a healthy vaginal flora. The product is free from fragrances, colorants, and parabens, and is intended for intravaginal application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HydroSanta Vaginalgel.